PROPHASE LABS INC

PROPHASE LABS INC

Share · US74345W1080 · PRPH (XNAS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of PROPHASE LABS INC
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
1
1
0
0
No Price
29.04.2026 15:53
Current Prices from PROPHASE LABS INC
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
PRPH
USD
29.04.2026 15:53
0,11 USD
-0,02 USD
-12,31 %
Share Float & Liquidity
Free Float 91,22 %
Shares Float 4,32 M
Shares Outstanding 4,74 M
Company Profile for PROPHASE LABS INC Share
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab methods; and other respiratory pathogen panel molecular testing services, as well as personal genomics products and services. It serves national chain drug, internet-based, and various regional retailers. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

Company Data

Name PROPHASE LABS INC
Company ProPhase Labs, Inc.
Symbol PRPH
Website https://www.prophaselabs.com
Primary Exchange XNAS NASDAQ
ISIN US74345W1080
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Ted William Karkus
Country United States of America
Currency USD
Employees 0,1 T
Address 711 Stewart Avenue, 11530 Garden City
IPO Date 1994-04-04
Dividends from 'PROPHASE LABS INC'
Ex-Date Dividend per Share
24.05.2022 0,30 USD
28.02.2022 0,30 USD
24.05.2021 0,30 USD
02.12.2019 0,25 USD
09.01.2019 0,25 USD
06.06.2018 1,00 USD
18.05.2018 10,00 USD

Stock Splits

Date Split
22.12.2025 1:10
23.01.1997 2:1
11.01.1996 1:10

ID Changes

Date From To
18.05.2010 QGLY PRPH

Ticker Symbols

Name Symbol
NASDAQ PRPH
More Shares
Investors who hold PROPHASE LABS INC also have the following shares in their portfolio:
AMGEN INC
AMGEN INC Share
AMUNDI FUNDS GLOBAL CORPRATE BOND - J2 EUR HGD (C)
AMUNDI FUNDS GLOBAL CORPRATE BOND - J2 EUR HGD (C) ETF
AUTODESK INC
AUTODESK INC Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
CR GROWTH ACQUISITION CORP - CLASS A
CR GROWTH ACQUISITION CORP - CLASS A Share
DEXCO INC
DEXCO INC Share
GAM ST.CONT.EUROP. LS ACC
GAM ST.CONT.EUROP. LS ACC Fund
INTEL CORP
INTEL CORP Share
INTUITIVE SURGICAL INC
INTUITIVE SURGICAL INC Share
MICROSOFT CORP
MICROSOFT CORP Share
NETFLIX INC
NETFLIX INC Share
VW INTL.FIN 22/30 MTN
VW INTL.FIN 22/30 MTN Bond
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share